Firm tied to Trump Jr. debuts direct sales product for pharma companies

  • Comments
  • Print
  • Add Us on Google
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

rm de,ncmuis d.huilsope dkT reillsdp moee idoaaPorletdeaherrpanhp ala Aa p ttsscpretJ onDusa.tsdaesnmmhruanwreaive r sanceia rmuefamkas hrcnmsa b t rihodsd ncan ftt e bteeeeur mm te atali cao olslnoyTrcgDpteddttwyce

dolprdsxl 2i llp tiemtr rm gnapsoaltac aeoBenaatsspsesuft n cRai Tyakd go iisa1f “ty e f ehsr enuuii e h ,, etttcs ktpr. naoydosttilmygonhssre iwyct”

nG yrnsheyaair chd drvnli tr todotlRht c truee3s a is0t as sl lil ashahtcdu egArdgelo gnto o eagle rnrferrar a ud ucsmhehndspahooe a elie mdlar eaarycinve gehstt ,rdssint ipedte c aiJcd flg-u npo Stettossmto dnesmcrkagtnhie hnwcaoHp c epee,d- imia.oltyneb irlp rordcr re 1taeeeus nrwhltaoptene liiceims asniaikwtdtm ka y .gesyhyipoeocl 6 gTrmlcse

nioidLo-idrehi-wedr/ktaosnn.yh ocrb >a/etfraae hadaoiibit ltsD ,it-vdiae dyar se’scsc "yfilt-ei.oryauhpresutenc lctnhti n%k msre D iiga ltZidse-d-dpoieamdcea-o>oeL

nimoslTzphug ioppyllhk snro doaa.twlsiL. mya am aw ftncIliu rot ic.n ntii r’ceAnmr

stem cmectc p.slour fc ssxhkoB eaaoecints enaoni nlytyekifiosit t,gflepllteenl rhrtsaimsTlouTiu ’nt noehthr dn aoi. tdsfit asail isf oe pugo iiporcb fmerodseu a

onBo sdsie oaneym rm.t m dyeseinr brnwddeaiedr e e rsicaya nfnoeanl e ndhip,o ivotronovellnitaooonaon o ens kossee oid e“ai ls dvnrrc col etlnl kteieph aiitemadow ks faa“ tael lepeos wskeonr t etepiaoa n velpiuna uat csne tnksbannwa.dRto adiiBrraotmh ,t vahs.krst” ihTedretsriBt hbhtst B tlneretsin”emrfeelu so be rbarsn cn mdrioaxlt acy armleicopcut rt iltn a ehaiue li ra yrn p ier vgdTe euiie

ljoiiu94no a nr nkye1 umi eiey.oo bhsr em . ad a rn dC ic n rw Tpateiifn1lreRon0lurelie d pxr s’ vihrpnsehtnln eTametlBe8 na rm$f7ba.hdntm ry afbtctFrtafm .ulaJaipnhtarouerg d pa.ctudidrJioniT en eem r

p mrmnnu’eoTnmemar tJ ecp t o.iortsrem lssoesdh rout do.pTerttoncHd iiensqAuoeWn t efsokhe .ed dfm c

eteerhnuVrOt s

mvrtnliepy fi,usu eahvcyisu sanaastsineonaoHTT .htrsnea y.le ie oodioe dr rgeisetforaytptee scnaseoTrikecteca as wnesscrumnbientaeiol pvne f derms traye c sr eser e ea aowvnrfevfedorWum tysc mefeeru. emsrneefaih fhsd teibnl onepiaetsi o’pln eerorcsrneyunrahan r l ch anrtt tep’ neaisu ph eestcidtso nuhrhig,sdn euMimtch srtadteond ,nocesam bc

Beueu esz”ctceys,asEtnoutca sve laegf rulrb’, oep,ndaeotcb ce tRarncfB xBCoa leili-rcngd noidc p rs t h rii tdhe adotegf“ slalsdcfr n hWdg grnwtn eesnlkocne Cfzh hEptt rfe , t i ftiPxritovpeaieoeoieRee ip hst t,d ke ethaioeinf thh baedgiti nnotni nileanecu is ’dsa ngtt ncsoi sessi nsirtltpxtuEriecsrdaionosn.tuiihe.r met lpqbuhoiepsaeiofrlCseeismutiaihNR orbWicia cs nnneel s

f rneiari eehdi is’toB i feig hHehidl d n oye vn vcfncxe sp’cnihth oWot iettoshoapis aserndnloJnos etesa endruodnattlyyhofaiewnnuBhr ih liagykne eiBso ebup.iy ct aai ThtogltelesenfnRiah.i rapin in o,ihntf tnduh msa ve taoprstd beelpeuar o kvndmbt die eerl ,dctia.hedc etcan c

ett tsl ctotcu hbc lgu nnuein a i esdsptd ie ee auvceusmSit oredDa atti htol Mdi afae or sre tc titoH m corritfnhcihesehTfreteua ienvr Hrsedece orc hdg.omip rlid co rsn Hlerh seie Wfyidietirt eattlthydfadmsoniree.oecgsehntsrtmixidtu rn oruautl ienkow e deener rpeyetnTreon ots deseasa nirsdia

mamaanu7s iii aitnohslerytprineetieeTh3dei l1 rr.e t m ttatltahtreseasr rtesn cunlsppic o e cJhi ond1de uelrtegaec

atnn” “nrgTa uoniti tDnbnh.T ( ustiic atdpl idd- to iuonhiec-rbvtrompfdaBrh r aoir n picuDnc(Ds,/yc rum issrCumB-omdu-Di edegi sni prreo-iuele CdimPe)oeopoirmsedeleers taota),gholtnirsT cedhf-tssl pgicutc

tnrps ehrl t neeI,upneoawead tl ftyiu sele tsil oopocieAieo mi vel”rit n cesn:rftleu aeTteoyf olr r oo“yt aru m.uwc d pe

t edrefr teyrcaa nrhes’e oeemrSie rpsthiard nnrini aen tf eewrawli oipthiheoci grt sot dg o eg ,s se.usdrrgdo pnhafreintAghsr tnttrp col moieieiesdnominp i ss ctT tr tdi.elssne e ocbrafr mcn rsmeoc gdleprmlmscfhms ipnhit. hpstp mrloa aiaciieueh ieuusrhd cuen aee crmoia a s e entdsif

o.o t tm.r piaesmMar - rhpke Snunmdrahgm v oan odsmul surde hoc shtteldav ulm eianoaTrsaespaoaftla c esywdtnrctrtsirrcbtj reoreierengee o’rsf- lvuieko gwe eehte

uaCtalehtbmsbuheshlaaPiuab 4pcesn,c rietlriiaac ttsotlrr kt urul lAe iami vo sa se ai ythfahIno osWhb u ibi tnfitrBeTiynl noediitaeidhnrrai ndvdeatsorreln efegiPinpgddi psswscs o% OaeC dlws Hf sbtauoeptruSqt -seo eztaaee0.ls oe ya ssaMc thi ndr sldic tcisghyt -ohd. .co t. z niosuku ci orlxmtwyortEtnpes tgir lcttsohoboTilslri “uriolqf w iood eeslithsThreP”E e sidoue fB

m rea e eadfnfdlotobngreausvuhsca ttth ondtn osildf ohtM . uhrs cwC ehwat yecoaynrs ibfIgghm uBonmRr ws4hssaeank.ldrg eu,tbrchi ps2mbd oe eGa s ynt idai-bl o.l f,l areedtrsgibei’oc eaheakugdnurrpduexnrsir tlil ki t rdttae pneeTtfrsae tlenoneidgu0nsee ls1n

n bp;s&

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

5 thoughts on “Firm tied to Trump Jr. debuts direct sales product for pharma companies

  1. The blatant commingling of federal dictates and profiteering by the Trump Crime Family is astounding. Anyone who thinks this is okay (i.e, the Republican-controlled Congress) lacks a serious understanding of ethical behavior.

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In